279 related articles for article (PubMed ID: 32605642)
1. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): A United Kingdom population-based cohort study using the health improvement network (THIN).
Vusirikala A; Thomas T; Bhala N; Tahrani AA; Thomas GN; Nirantharakumar K
BMC Endocr Disord; 2020 Jun; 20(1):96. PubMed ID: 32605642
[TBL] [Abstract][Full Text] [Related]
2. Association between metabolically healthy obesity and non-alcoholic fatty liver disease.
Man S; Lv J; Yu C; Deng Y; Yin J; Wang B; Li L; Liu H
Hepatol Int; 2022 Dec; 16(6):1412-1423. PubMed ID: 35987840
[TBL] [Abstract][Full Text] [Related]
3. The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
Kouvari M; Chrysohoou C; Skoumas J; Pitsavos C; Panagiotakos DB; Mantzoros CS;
Metabolism; 2022 Mar; 128():154893. PubMed ID: 34600906
[TBL] [Abstract][Full Text] [Related]
4. Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity.
Man S; Deng Y; Ma Y; Yang X; Wang X; Fu J; Yu C; Lv J; Du J; Wang B; Li L
Obes Res Clin Pract; 2024; 18(2):109-117. PubMed ID: 38443283
[TBL] [Abstract][Full Text] [Related]
5. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
6. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
[TBL] [Abstract][Full Text] [Related]
7. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
[TBL] [Abstract][Full Text] [Related]
8. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
[TBL] [Abstract][Full Text] [Related]
9. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity.
Lonardo A; Mantovani A; Lugari S; Targher G
Ann Hepatol; 2020; 19(4):359-366. PubMed ID: 32349939
[TBL] [Abstract][Full Text] [Related]
11. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
Du T; Yu X; Yuan G; Zhang J; Sun X
Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
[TBL] [Abstract][Full Text] [Related]
12.
Sakamoto Y; Oniki K; Kumagae N; Morita K; Otake K; Ogata Y; Saruwatari J
Dis Markers; 2019; 2019():4065327. PubMed ID: 31929840
[TBL] [Abstract][Full Text] [Related]
13. Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study.
Najafi F; Pasdar Y; Nazar MM; Darbandi M
BMC Endocr Disord; 2024 Jun; 24(1):96. PubMed ID: 38918729
[TBL] [Abstract][Full Text] [Related]
14. Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population.
Wei Y; Wang J; Han X; Yu C; Wang F; Yuan J; Miao X; Yao P; Wei S; Wang Y; Liang Y; Zhang X; Guo H; Zheng D; Tang Y; Yang H; He M
Diabetes Metab Res Rev; 2020 Jan; 36(1):e3202. PubMed ID: 31291052
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis.
Lavrentaki A; Thomas T; Subramanian A; Valsamakis G; Thomas N; Toulis KA; Wang J; Daly B; Saravanan P; Sumilo D; Mastorakos G; Tahrani AA; Nirantharakumar K
J Diabetes Complications; 2019 Oct; 33(10):107401. PubMed ID: 31326267
[TBL] [Abstract][Full Text] [Related]
16. Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study.
Wang J; Niratharakumar K; Gokhale K; Tahrani AA; Taverner T; Thomas GN; Dasgupta I
Am J Kidney Dis; 2022 Jan; 79(1):24-35.e1. PubMed ID: 34146618
[TBL] [Abstract][Full Text] [Related]
17. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Endocrinol; 2019 Aug; 181(2):185-192. PubMed ID: 31176297
[TBL] [Abstract][Full Text] [Related]
18. The Association Between Nonalcoholic Fatty Liver Disease and Metabolic Abnormalities in The United States Population.
Jinjuvadia R; Antaki F; Lohia P; Liangpunsakul S
J Clin Gastroenterol; 2017 Feb; 51(2):160-166. PubMed ID: 27580477
[TBL] [Abstract][Full Text] [Related]
19. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.
Jarvis H; Craig D; Barker R; Spiers G; Stow D; Anstee QM; Hanratty B
PLoS Med; 2020 Apr; 17(4):e1003100. PubMed ID: 32353039
[TBL] [Abstract][Full Text] [Related]
20. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
